drugset / Trial / NCT00797927

Quetiapine Related Neurochemical Changes as Measured by Magnetic Resonance Spectroscopy in Schizophrenia

NCT00797927

Non-randomizedParallel-groupOpen-labelTreatment

Summary

we aim to examine whether a representative atypical antipsychotic, quetiapine, has different effects from conventional antipsychotics on the magnetic resonance spectroscopy (MRS) markers in schizophrenia patients.

Timeline

Start
2007-01
Primary completion
2009-03
Completion
2009-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Quetiapine Small molecule

Indications